Suchergebnisse - "Lubin, Joseph H"

PubPharm (22)

1

Structural models of SARS-CoV-2 Omicron variant in complex with ACE2 receptor or antibodies suggest altered binding interfaces

enthalten in: bioRxiv.org | 2024

von Lubin, J. | Markosian, C. | Balamurugan, D. | +4

2

Prediction and design of protease enzyme specificity using a structure-aware graph convolutional network

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Lu, C. | Lubin, J. | Sarma, V. | +4

UpdateOf: bioRxiv. 2023 Feb 16;:. - PMID 36824945

3

Corrigendum to "Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus" [Heliyon 9(4) (April 2023) e15032

enthalten in: Heliyon | 2023

von Hernandez, N. | Jankowski, W. | Frick, R. | +8

ErratumFor: Heliyon. 2023 Apr;9(4):e15032. - PMID 37035348

4

Modeling of ACE2 and antibodies bound to SARS-CoV-2 provides insights into infectivity and immune evasion

enthalten in: JCI insight | 2023

von Lubin, J. | Markosian, C. | Balamurugan, D. | +7

UpdateOf: bioRxiv. 2021 Dec 13;:. - PMID 34931193

5

Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus

enthalten in: Heliyon | 2023

von Hernandez, N. | Jankowski, W. | Frick, R. | +8

ErratumIn: Heliyon. 2023 Jul 06;9(8):e17901. - PMID 37701412

6

Prediction and Design of Protease Enzyme Specificity Using a Structure-Aware Graph Convolutional Network

enthalten in: bioRxiv.org | 2023

von Lu, C. | Lubin, J. | Sarma, V. | +4

7

Prediction and Design of Protease Enzyme Specificity Using a Structure-Aware Graph Convolutional Network

enthalten in: bioRxiv : the preprint server for biology | 2023

von Lu, C. | Lubin, J. | Sarma, V. | +4

UpdateIn: Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2303590120. - PMID 37729196

8

A comprehensive survey of coronaviral main protease active site diversity in 3D: Identifying and analyzing drug discovery targets in search of broad specificity inhibitors for the next coronavirus pandemic

enthalten in: bioRxiv.org | 2023

von Lubin, J. | Martinusen, S. | Zardecki, C. | +10

9

A comprehensive survey of coronaviral main protease active site diversity in 3D : Identifying and analyzing drug discovery targets in search of broad specificity inhibitors for the next coronavirus pandemic

enthalten in: bioRxiv : the preprint server for biology | 2023

von Lubin, J. | Martinusen, S. | Zardecki, C. | +10

10

Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemic

enthalten in: Proteins | 2022

von Lubin, J. | Zardecki, C. | Dolan, E. | +61

UpdateOf: bioRxiv. 2020 Dec 07;:. - PMID 33299989